Examining Unmet Needs for Patients with Vasomotor Symptoms Due to MENOPAUSE: Challenges with Traditional Therapeutic Options and the Rationale for Novel Treatments
Pre-test
Questions marked with a
*
are required
100%
Contact Information
First Name
Last Name
Email Address
Jack is a 75-yo man with a history of mild short-term memory complaints over the past 6-12 months. His mother and brother both had AD. He can still work (attorney), drive, play tennis, and travel. Medical history includes HTN, BPH, hyperlipidemia, gout, lower back pain, right knee replacement, primary insomnia, and obstructive sleep apnea (uses CPAP, doing well on 10 cm H2O). Medications: atenolol, finasteride, lovastatin, allopurinol, MVI, ASA, zolpidem 10 mg, PRN NSAID, and hydrocodone for back pain. Which of the following should be assessed as potential contributors to this patient’s short-term memory loss?
Medications and hypertension.
Back pain.
BPH and gout.
History of surgery (knee replacement).
Dysfunction in which of the following domains would best be described as impairment in planning, organizing, and completing tasks/projects?
Complex attention.
Executive function.
Learning and memory.
Perceptual-motor.
Social cognition.
Choosing initial treatment for mild cognitive impairment or Alzheimer’s disease, and continuing or altering subsequent treatment should always include which of the following?
Outlining that Alzheimer’s disease is ultimately a curable disease.
Focusing on memory alone as the primary target of treatment.
Making shared decisions together with the patient to help maximize patient engagement and adherence.
Continuing the same treatment regimen when there’s major breakthrough activity.
Which of the following is true regarding multidisciplinary care for patients with Alzheimer’s disease?
The responsibility of leading the care team and coordinating treatment for Alzheimer’s disease should rest almost exclusively on primary care clinicians.
While PCPs should exercise shared decision-making with patients, specialists should dictate to patients what treatments they should take.
Generally, in a patient with Alzheimer’s disease, cardiovascular health is not a factor in overall treatment goals.
Comprehensive treatment of Alzheimer’s disease includes primary care, neurology, geriatrics, neuropsychology, palliative care, and several other caregivers.
Done
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close